Greenleaf Trust Sells 56 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Greenleaf Trust lessened its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.5% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,565 shares of the biotechnology company’s stock after selling 56 shares during the period. Greenleaf Trust’s holdings in Axon Enterprise were worth $930,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Asset Dedication LLC lifted its position in Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after acquiring an additional 18 shares during the last quarter. Insigneo Advisory Services LLC boosted its stake in Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after purchasing an additional 22 shares during the period. Menard Financial Group LLC grew its holdings in Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after buying an additional 24 shares in the last quarter. PFG Investments LLC increased its position in Axon Enterprise by 0.6% during the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after buying an additional 25 shares during the period. Finally, Gladstone Institutional Advisory LLC lifted its holdings in shares of Axon Enterprise by 1.6% during the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after buying an additional 26 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

AXON has been the topic of several research reports. TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Needham & Company LLC raised their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Robert W. Baird boosted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Finally, JMP Securities lifted their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $524.85.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $658.11 on Tuesday. The company’s 50 day moving average price is $620.41 and its two-hundred day moving average price is $486.16. The firm has a market capitalization of $50.18 billion, a P/E ratio of 170.05, a P/E/G ratio of 6.54 and a beta of 1.05. Axon Enterprise, Inc. has a fifty-two week low of $252.20 and a fifty-two week high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now owns 154,394 shares of the company’s stock, valued at $91,691,508.72. The trade was a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,545 shares of company stock worth $30,721,337. Insiders own 5.70% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.